Update in Pediatric Endocrinology

  • Seth D. MarksEmail author
  • Brandy A. Wicklow


Endocrine disorders refer to disease states affecting the glands that produce hormones regulating metabolism, growth, development, sexual function and other bodily functions. Disorders of the adrenal glands, growth, puberty, and the thyroid are cornerstones of pediatric endocrinology. While the endocrine care of children has much overlap with the endocrine care of adults, there are many unique aspects of pediatric endocrinology. Growth and puberty are obviously unique to the care of children. Thyroid and adrenal disorders in children have similarities to these disorders in adults but there are some important differences and nuances in the care of these disorders in children. The purpose of this chapter is not to provide an exhaustive review but rather to highlight some concepts of pediatric endocrine care including some recent updates.


Adrenal Cortisol Glucocorticoid Endocrinology Gonadotropin Growth Hypothalamus l-Thyroxine Pituitary Puberty Short Stature Thyroid 


  1. Abreu AP, Dauber A, Macedo DB, Noel SD, Brito VN, Gill JC, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368(26):2467–75. PubMed PMID: 23738509. Pubmed Central PMCID: PMC3808195. Epub 2013/06/07. engCrossRefPubMedGoogle Scholar
  2. Addison T. On the constitutional and local effects of disease of the supra-renal capsules. Special ed. Birmingham: Classics of Medicine Library; 1980.Google Scholar
  3. Albanese A, Kewley GD, Long A, Pearl KN, Robins DG, Stanhope R. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate. Arch Dis Child. 1994;71(4):315–7. PubMed PMID: 7979523. Pubmed Central PMCID: PMC1030008. Epub 1994/10/01. engCrossRefPubMedPubMedCentralGoogle Scholar
  4. Allen DB, Cuttler L. Clinical practice. Short stature in childhood—challenges and choices. N Engl J Med. 2013;368(13):1220–8. PubMed PMID: 23534561. Epub 2013/03/29. engCrossRefPubMedPubMedCentralGoogle Scholar
  5. Bellone J, Valetto MR, Aimaretti G, Segni M, Volta C, Cardimale G, et al. Effects of phenylalanine, histidine, and leucine on basal and GHRH-stimulated GH secretion and on PRL, insulin, and glucose levels in short children. Comparison with the effects of arginine. J Pediatr Endocrinol Metab. 1996;9(5):523–31. PubMed PMID: 8961128. Epub 1996/09/01. engCrossRefPubMedGoogle Scholar
  6. Berglund A, Gravholt CH, Olsen MS, Christiansen JS, Stochholm K. Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency. Clin Endocrinol. 2015;83(5):677–83. PubMed PMID: 26147754. Epub 2015/07/07. engCrossRefGoogle Scholar
  7. Binder G, Schweizer R, Haber P, Blumenstock G, Braun R. Accuracy of endocrine tests for detecting hypogonadotropic hypogonadism in girls. J Pediatr. 2015;167(3):674–8. e1. PubMed PMID: 26095287. Epub 2015/06/23. engCrossRefPubMedGoogle Scholar
  8. Biro FM, Galvez MP, Greenspan LC, Succop PA, Vangeepuram N, Pinney SM, et al. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics. 2010;126(3):e583–90. PubMed PMID: 20696727. Pubmed Central PMCID: PMC4460992.Epub 2010/08/11. engCrossRefPubMedPubMedCentralGoogle Scholar
  9. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–89. PubMed PMID: 26760044. Pubmed Central PMCID: PMC4880116. Epub 2016/01/14. engCrossRefPubMedGoogle Scholar
  10. Butler MG, Lee J, Manzardo AM, Gold JA, Miller JL, Kimonis V, et al. Growth charts for non-growth hormone treated Prader-Willi syndrome. Pediatrics. 2015;135(1):e126–35. PubMed PMID: 25489013. Pubmed Central PMCID: PMC4279067. Epub 2014/12/10. engCrossRefPubMedPubMedCentralGoogle Scholar
  11. Cai Y, Xu M, Yuan M, Liu Z, Yuan W. Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes. Int J Nanomedicine. 2014;9:3527–38. PubMed PMID: 25114523. Pubmed Central PMCID: PMC4122423. Epub 2014/08/13. engPubMedPubMedCentralGoogle Scholar
  12. Carel JC, Tresca JP, Letrait M, Chaussain JL, Lebouc Y, Job JC, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab. 1997;82(7):2117–21. PubMed PMID: 9215281. Epub 1997/07/01. engCrossRefPubMedGoogle Scholar
  13. Carel JC, Ecosse E, Landier F, Meguellati-Hakkas D, Kaguelidou F, Rey G, et al. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab. 2012;97(2):416–25. PubMed PMID: 22238382. Epub 2012/01/13. engCrossRefPubMedGoogle Scholar
  14. Chen M, Eugster EA. Central precocious puberty: update on diagnosis and treatment. Paediatr Drugs. 2015;17(4):273–81. PubMed PMID: 25911294. Epub 2015/04/26. engCrossRefPubMedPubMedCentralGoogle Scholar
  15. Chi CH, Durham E, Neely EK. Pharmacodynamics of aqueous leuprolide acetate stimulation testing in girls: correlation between clinical diagnosis and time of peak luteinizing hormone level. J Pediatr. 2012;161(4):757–9. e1. PubMed PMID: 22809662. Epub 2012/07/20. engCrossRefPubMedGoogle Scholar
  16. Cohen LE. Idiopathic short stature: a clinical review. JAMA. 2014;311(17):1787–96. PubMed PMID: 24794372. Epub 2014/05/06. engCrossRefPubMedGoogle Scholar
  17. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210–7. PubMed PMID: 18782877. Epub 2008/09/11. engCrossRefPubMedPubMedCentralGoogle Scholar
  18. Coutant R, de Casson FB, Rouleau S, Douay O, Mathieu E, Gatelais F, et al. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J Clin Endocrinol Metab. 2004;89(12):6185–92. PubMed PMID: 15579776. Epub 2004/12/08. engCrossRefPubMedGoogle Scholar
  19. DeBoer MD, Denson LA. Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn’s disease: despite temporal changes in disease severity, the need for monitoring remains. J Pediatr. 2013;163(1):17–22. PubMed PMID: 23522861. Pubmed Central PMCID: PMC3692567. Epub 2013/03/26. engCrossRefPubMedPubMedCentralGoogle Scholar
  20. Dunkel L. Treatment of idiopathic short stature: effects of gonadotropin-releasing hormone analogs, aromatase inhibitors and anabolic steroids. Horm Res Paediatr. 2011;76(Suppl 3):27–9. PubMed PMID: 21912156. Epub 2011/09/23. engCrossRefPubMedGoogle Scholar
  21. Ferguson KK, Peterson KE, Lee JM, Mercado-Garcia A, Blank-Goldenberg C, Tellez-Rojo MM, et al. Prenatal and peripubertal phthalates and bisphenol A in relation to sex hormones and puberty in boys. Reprod Toxicol (Elmsford, NY). 2014;47:70–6. PubMed PMID: 24945889. Pubmed Central PMCID: PMC4117729. Epub 2014/06/20. engCrossRefGoogle Scholar
  22. Freriks K, Sas TC, Traas MA, Netea-Maier RT, den Heijer M, Hermus AR, et al. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome. Eur J Endocrinol. 2013;168(1):91–9. PubMed PMID: 23076845. Epub 2012/10/19. engCrossRefPubMedGoogle Scholar
  23. Fuld K, Chi C, Neely EK. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty. J Pediatr. 2011;159(6):982–7. e1. PubMed PMID: 21798557. Epub 2011/07/30. engCrossRefPubMedGoogle Scholar
  24. Giustina A, Scalvini T, Tassi C, Desenzani P, Poiesi C, Wehrenberg WB, et al. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab. 1997;82(4):1210–9. PubMed PMID: 9100598. Epub 1997/04/01. engPubMedGoogle Scholar
  25. van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, et al. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. J Clin Endocrinol Metab. 2007;92(4):1402–8. PubMed PMID: 17284626. Epub 2007/02/08. engCrossRefPubMedGoogle Scholar
  26. Harrington J, Palmert MR. Clinical review: distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab. 2012;97(9):3056–67. PubMed PMID: 22723321. Epub 2012/06/23. engCrossRefPubMedGoogle Scholar
  27. Herman-Giddens ME, Steffes J, Harris D, Slora E, Hussey M, Dowshen SA, et al. Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network. Pediatrics. 2012;130(5):e1058–68. PubMed PMID: 23085608. Epub 2012/10/23. engCrossRefPubMedGoogle Scholar
  28. Hilczer M, Smyczynska J, Lewinski A. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature. Endocr Regul. 2006;40(3):69–75. PubMed PMID: 17100548. Epub 2006/11/15. engPubMedGoogle Scholar
  29. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87(9):4048–53. PubMed PMID: 12213842. Epub 2002/09/06. engCrossRefGoogle Scholar
  30. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–751. PubMed PMID: 25266247. Pubmed Central PMCID: PMC4267409. Epub 2014/10/01. engCrossRefPubMedPubMedCentralGoogle Scholar
  31. Kamath C, Adlan MA, Premawardhana LD. The role of thyrotrophin receptor antibody assays in graves' disease. J Thyroid Res. 2012;2012:525936. PubMed PMID: 22577596. Pubmed Central PMCID: PMC3345237. Epub 2012/05/12. engCrossRefPubMedPubMedCentralGoogle Scholar
  32. Kapadia CR, Nebesio TD, Myers SE, Willi S, Miller BS, Allen DB, et al. Endocrine effects of inhaled corticosteroids in children. JAMA Pediatr. 2016;170(2):163–70. PubMed PMID: 26720105. Epub 2016/01/01. engCrossRefPubMedGoogle Scholar
  33. Karras S, Memi E, Kintiraki E, Krassas GE. Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts. J Pediatr Endocrinol Metab. 2012;25(7–8):623–30. PubMed PMID: 23155684. Epub 2012/11/20. engPubMedGoogle Scholar
  34. Koch HM, Wittassek M, Bruning T, Angerer J, Heudorf U. Exposure to phthalates in 5-6 years old primary school starters in Germany—a human biomonitoring study and a cumulative risk assessment. Int J Hyg Environ Health. 2011;214(3):188–95. PubMed PMID: 21371937. Epub 2011/03/05. engCrossRefPubMedGoogle Scholar
  35. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2002;246:1–190. PubMed PMID: 12043359. Epub 2002/06/05. engGoogle Scholar
  36. Lafranchi S. Thyroiditis and acquired hypothyroidism. Pediatr Ann. 1992;21(1):29–39. PubMed PMID: 1549397. Epub 1992/01/01. engCrossRefPubMedGoogle Scholar
  37. Lawrence S, Cummings E, Chanoine JP, Metzger DL, Palmert M, Sharma A, et al. Canadian Pediatric Endocrine Group extension to WHO growth charts: why bother? Paediatr Child Health. 2013;18(6):295–7. PubMed PMID: 24421695. Pubmed Central PMCID: PMC3680249. Epub 2014/01/15. engCrossRefPubMedPubMedCentralGoogle Scholar
  38. Lawrence S, Cummings E, Chanoine JP, Metzger D, Palmert M, Sharma A, et al. Use of growth charts in Canada: A National Canadian Paediatric Surveillance Program survey. Paediatr Child Health. 2015;20(4):185–8. PubMed PMID: 26038634. Pubmed Central PMCID: PMC4443823. Epub 2015/06/04. engCrossRefPubMedPubMedCentralGoogle Scholar
  39. Lazar L, Frumkin RB, Battat E, Lebenthal Y, Phillip M, Meyerovitch J. Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab. 2009;94(5):1678–82. PubMed PMID: 19240148. Epub 2009/02/26. engCrossRefPubMedGoogle Scholar
  40. Lee HS, Hwang JS. The treatment of Graves' disease in children and adolescents. Ann Pediatr Endocrinol Metab. 2014;19(3):122–6. PubMed PMID: 25346915. Pubmed Central PMCID: PMC4208256. Epub 2014/10/28. engCrossRefPubMedPubMedCentralGoogle Scholar
  41. Lee PA, Klein K, Mauras N, Lev-Vaisler T, Bacher P. 36-Month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty. J Clin Endocrinol Metab. 2014;99(9):3153–9. PubMed PMID: 24926950. Epub 2014/06/14. engCrossRefPubMedGoogle Scholar
  42. Leger J, Gelwane G, Kaguelidou F, Benmerad M, Alberti C. Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves’ disease: national long-term cohort study. J Clin Endocrinol Metab. 2012;97(1):110–9. PubMed PMID: 22031519. Epub 2011/10/28. engCrossRefPubMedGoogle Scholar
  43. Lewis KA, Goldyn AK, West KW, Eugster EA. A single histrelin implant is effective for 2 years for treatment of central precocious puberty. J Pediatr. 2013;163(4):1214–6. PubMed PMID: 23809043. Pubmed Central PMCID: PMC4063525. Epub 2013/07/03. engCrossRefPubMedPubMedCentralGoogle Scholar
  44. Lomniczi A, Wright H, Castellano JM, Sonmez K, Ojeda SR. A system biology approach to identify regulatory pathways underlying the neuroendocrine control of female puberty in rats and nonhuman primates. Horm Behav. 2013;64(2):175–86. PubMed PMID: 23998662. Pubmed Central PMCID: PMC3933372. Epub 2013/09/04. engCrossRefPubMedPubMedCentralGoogle Scholar
  45. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab. 1994;79(2):537–41. PubMed PMID: 8045974. Epub 1994/08/01. engPubMedGoogle Scholar
  46. Martin DD, Wit JM, Hochberg Z, Savendahl L, van Rijn RR, Fricke O, et al. The use of bone age in clinical practice – part 1. Horm Res Paediatr. 2011a;76(1):1–9. PubMed PMID: 21691054. Epub 2011/06/22. engCrossRefPubMedGoogle Scholar
  47. Martin DD, Wit JM, Hochberg Z, van Rijn RR, Fricke O, Werther G, et al. The use of bone age in clinical practice – part 2. Horm Res Paediatr. 2011b;76(1):10–6. PubMed PMID: 21691055. Epub 2011/06/22. engCrossRefPubMedGoogle Scholar
  48. Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID, et al. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J Clin Endocrinol Metab. 2008;93(3):823–31. PubMed PMID: 18165285. Pubmed Central PMCID: PMC2266949.Epub 2008/01/01. engCrossRefPubMedGoogle Scholar
  49. Mericq MV, Eggers M, Avila A, Cutler GB Jr, Cassorla F. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab. 2000;85(2):569–73. PubMed PMID: 10690857. Epub 2000/02/26. engPubMedGoogle Scholar
  50. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics. 2003;111(1):47–51. PubMed PMID: 12509553. Epub 2003/01/02. engCrossRefPubMedGoogle Scholar
  51. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80(12):3689–98. PubMed PMID: 8530621. Epub 1995/12/01. engPubMedGoogle Scholar
  52. Mul D, Wit JM, Oostdijk W, Van den Broeck J. The effect of pubertal delay by GnRH agonist in GH-deficient children on final height. J Clin Endocrinol Metab. 2001;86(10):4655–6. PubMed PMID: 11600521. Epub 2001/10/16. engCrossRefPubMedGoogle Scholar
  53. Murray PG, Dattani MT, Clayton PE. Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence. Arch Dis Child. 2016;101(1):96–100. PubMed PMID: 26153506. Epub 2015/07/15. engCrossRefPubMedGoogle Scholar
  54. Natale V, Rajagopalan A. Worldwide variation in human growth and the World Health Organization growth standards: a systematic review. BMJ Open. 2014;4(1):e003735. PubMed PMID: 24401723. Pubmed Central PMCID: PMC3902406. Epub 2014/01/10. engCrossRefPubMedPubMedCentralGoogle Scholar
  55. Owen BM, Bookout AL, Ding X, Lin VY, Atkin SD, Gautron L, et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat Med. 2013;19(9):1153–6. PubMed PMID: 23933983. Pubmed Central PMCID: PMC3769455. Epub 2013/08/13. engCrossRefPubMedPubMedCentralGoogle Scholar
  56. Palmert MR, Dunkel L. Clinical practice. Delayed puberty. N Engl J Med. 2012;366(5):443–53. PubMed PMID: 22296078. Epub 2012/02/03. engCrossRefPubMedGoogle Scholar
  57. Perry R, Kecha O, Paquette J, Huot C, Van Vliet G, Deal C. Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal. J Clin Endocrinol Metab. 2005;90(6):3243–50. PubMed PMID: 15811934. Epub 2005/04/07. engCrossRefPubMedGoogle Scholar
  58. Phelan N, Conway SH, Llahana S, Conway GS. Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice. Clin Endocrinol. 2012;76(5):729–33. PubMed PMID: 22098528. Epub 2011/11/22. engCrossRefGoogle Scholar
  59. Poidvin A, Touze E, Ecosse E, Landier F, Bejot Y, Giroud M, et al. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurology. 2014;83(9):780–6. PubMed PMID: 25122206. Epub 2014/08/15. engCrossRefPubMedGoogle Scholar
  60. Punthakee Z, Legault L, Polychronakos C. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J Pediatr. 2003;143(3):402–5. PubMed PMID: 14517528. Epub 2003/10/01. engCrossRefPubMedGoogle Scholar
  61. Quigley CA, Wan X, Garg S, Kowal K, Cutler GB Jr, Ross JL. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2014;99(9):E1754–64. PubMed PMID: 24762109. Pubmed Central PMCID: PMC4154082. Epub 2014/04/26.engCrossRefPubMedPubMedCentralGoogle Scholar
  62. Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, Cambiaso P, et al. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol. 2012;76(3):394–8. PubMed PMID: 21981142. Epub 2011/10/11. engCrossRefGoogle Scholar
  63. Raman S, Grimberg A, Waguespack SG, Miller BS, Sklar CA, Meacham LR, et al. Risk of neoplasia in pediatric patients receiving growth hormone therapy—a report from the Pediatric Endocrine Society Drug and Therapeutics Committee. J Clin Endocrinol Metab. 2015;100(6):2192–203. PubMed PMID: 25839904. Epub 2015/04/04. engCrossRefPubMedPubMedCentralGoogle Scholar
  64. Rivkees SA. Pediatric Graves’ disease: management in the post-propylthiouracil Era. Int J Pediatr Endocrinol. 2014;2014(1):10. PubMed PMID: 25089127. Pubmed Central PMCID: PMC4118280. Epub 2014/08/05. engCrossRefPubMedPubMedCentralGoogle Scholar
  65. Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab. 2010;95(7):3260–7. PubMed PMID: 20427502. Epub 2010/04/30. engCrossRefPubMedGoogle Scholar
  66. Rivkees SA, Sklar C, Freemark M. Clinical review 99: the management of Graves’ disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab. 1998;83(11):3767–76. PubMed PMID: 9814445. Epub 1998/11/14. engPubMedGoogle Scholar
  67. Rodd C, Metzger DL, Sharma A. Extending World Health Organization weight-for-age reference curves to older children. BMC Pediatr. 2014;14:32. PubMed PMID: 24490896. Pubmed Central PMCID: PMC3922078. Epub 2014/02/05. engCrossRefPubMedPubMedCentralGoogle Scholar
  68. Rose SR, Vogiatzi MG, Copeland KC. A general pediatric approach to evaluating a short child. Pediatr Rev. 2005;26(11):410–20. PubMed PMID: 16264029. Epub 2005/11/03. engPubMedCrossRefGoogle Scholar
  69. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117(6):2290–303. PubMed PMID: 16740880. Epub 2006/06/03. engCrossRefPubMedGoogle Scholar
  70. Rothenbuhler A, Ormieres B, Kalifa G, Bougneres P. A pilot study of growth hormone administration in boys with predicted adult short stature and near-ending growth. Growth Hormone IGF Res. 2015;25(2):96–102. PubMed PMID: 25641639. Epub 2015/02/03. engCrossRefGoogle Scholar
  71. Saggese G, Federico G, Barsanti S, Fiore L. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study. J Clin Endocrinol Metab. 2001;86(5):1900–4. PubMed PMID: 11344181. Epub 2001/05/10. engCrossRefPubMedGoogle Scholar
  72. Sas TC, Gault EJ, Bardsley MZ, Menke LA, Freriks K, Perry RJ, et al. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use. Horm Res Paediatr. 2014;81(5):289–97. PubMed PMID: 24776783. Epub 2014/04/30. engCrossRefPubMedGoogle Scholar
  73. Schroor EJ, van Weissenbruch MM, Knibbe P, Delemarre-van de Waal HA. The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty. Eur J Pediatr. 1995;154(12):953–7. PubMed PMID: 8801102. Epub 1995/12/01. engCrossRefPubMedGoogle Scholar
  74. Selva KA, Mandel SH, Rien L, Sesser D, Miyahira R, Skeels M, et al. Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr. 2002;141(6):786–92. PubMed PMID: 12461494. Epub 2002/12/04. engCrossRefPubMedGoogle Scholar
  75. Selva KA, Harper A, Downs A, Blasco PA, Lafranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr. 2005;147(6):775–80. PubMed PMID: 16356430. Epub 2005/12/17. engCrossRefPubMedGoogle Scholar
  76. Seminara SB. Kisspeptin in reproduction. Semin Reprod Med. 2007;25(5):337–43. PubMed PMID: 17710729. Epub 2007/08/22. engCrossRefPubMedGoogle Scholar
  77. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614–27. PubMed PMID: 14573733. Epub 2003/10/24. engCrossRefPubMedGoogle Scholar
  78. Shulman DI, Palmert MR, Kemp SF. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007;119(2):e484–94. PubMed PMID: 17242136. Epub 2007/01/24. engCrossRefPubMedGoogle Scholar
  79. Silverman LA, Neely EK, Kletter GB, Lewis K, Chitra S, Terleckyj O, et al. Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty: a final report of a phase 3 multicenter trial. J Clin Endocrinol Metab. 2015;100(6):2354–63. PubMed PMID: 25803268. Pubmed Central PMCID: PMC4504932. Epub 2015/03/25. engCrossRefPubMedPubMedCentralGoogle Scholar
  80. Smith DW, Truog W, Rogers JE, Greitzer LJ, Skinner AL, McCann JJ, et al. Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr. 1976;89(2):225–30. PubMed PMID: 940016. Epub 1976/08/01. engCrossRefPubMedGoogle Scholar
  81. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331(16):1056–61. PubMed PMID: 8090165. Epub 1994/10/20. engCrossRefPubMedGoogle Scholar
  82. Stanley TL, Levitsky LL, Grinspoon SK, Misra M. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab. 2009;94(12):4875–81. PubMed PMID: 19890023. Pubmed Central PMCID: PMC2795667. Epub 2009/11/06. engCrossRefPubMedPubMedCentralGoogle Scholar
  83. Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study. Lancet (London). 2002;360(9329):273–7. PubMed PMID: 12147369. Epub 2002/07/31. engCrossRefGoogle Scholar
  84. Tarquinio DC, Jones MC, Jones KL, Bird LM. Growth charts for 22q11 deletion syndrome. Am J Med Genet A. 2012;158A(11):2672–81. PubMed PMID: 22887711. Epub 2012/08/14. engCrossRefPubMedGoogle Scholar
  85. Touwslager RN, Gielen M, Derom C, Mulder AL, Gerver WJ, Zimmermann LJ, et al. Determinants of infant growth in four age windows: a twin study. J Pediatr. 2011a;158(4):566–72. e2. PubMed PMID: 21147487. Epub 2010/12/15. engCrossRefPubMedGoogle Scholar
  86. Touwslager RN, Gielen M, Mulder AL, Gerver WJ, Zimmermann LJ, Fowler T, et al. Changes in genetic and environmental effects on growth during infancy. Am J Clin Nutr. 2011b;94(6):1568–74. PubMed PMID: 22071713. Epub 2011/11/11. engCrossRefPubMedGoogle Scholar
  87. Weise M, Drinkard B, Mehlinger SL, Holzer SM, Eisenhofer G, Charmandari E, et al. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab. 2004;89(8):3679–84. PubMed PMID: 15292287. Epub 2004/08/05. engCrossRefPubMedGoogle Scholar
  88. WHO Multicentre Growth Reference Study Group. Assessment of differences in linear growth among populations in the WHO Multicentre Growth Reference Study. Acta Paediatr (Oslo 1992). 2006;450:56–65. PubMed PMID: 16817679. Epub 2006/07/05. engGoogle Scholar
  89. Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet (London). 2001;357(9270):1743–8. PubMed PMID: 11403810. Epub 2001/06/14. engCrossRefGoogle Scholar
  90. Wit JM, Oostdijk W. Novel approaches to short stature therapy. Best Pract Res Clin Endocrinol Metab. 2015;29(3):353–66. PubMed PMID: 26051296. Epub 2015/06/09. engCrossRefPubMedGoogle Scholar
  91. Wit JM, Hero M, Nunez SB. Aromatase inhibitors in pediatrics. Nat Rev Endocrinol. 2012;8(3):135–47. PubMed PMID: 22024975. Epub 2011/10/26. engCrossRefGoogle Scholar
  92. Wittassek M, Koch HM, Angerer J, Bruning T. Assessing exposure to phthalates - the human biomonitoring approach. Mol Nutr Food Res. 2011;55(1):7–31. PubMed PMID: 20564479. Epub 2010/06/22. engCrossRefPubMedGoogle Scholar
  93. Xie C, Zhao Y, Gao L, Chen J, Cai D, Zhang Y. Elevated phthalates' exposure in children with constitutional delay of growth and puberty. Mol Cell Endocrinol. 2015;407:67–73. PubMed PMID: 25770461. Epub 2015/03/17. engCrossRefPubMedGoogle Scholar
  94. Xie C, Epstein LH, Eiden RD, Shenassa ED, Li X, Liao Y, et al. Stunting at 5 years among SGA newborns. Pediatrics. 2016;137(2):e20152636. PubMed PMID: 26772663. Epub 2016/01/17. engCrossRefPubMedGoogle Scholar
  95. Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, et al. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med. 2003;348(10):908–17. PubMed PMID: 12621135. Epub 2003/03/07. engCrossRefPubMedGoogle Scholar
  96. Yazdani P, Lin Y, Raman V, Haymond M. A single sample GnRHa stimulation test in the diagnosis of precocious puberty. Int J Pediatr Endocrinol. 2012;2012(1):23. PubMed PMID: 22809285. Pubmed Central PMCID: PMC3438042. Epub 2012/07/20. engCrossRefPubMedPubMedCentralGoogle Scholar
  97. Zemel BS, Pipan M, Stallings VA, Hall W, Schadt K, Freedman DS, et al. Growth charts for children with down syndrome in the United States. Pediatrics. 2015;136(5):e1204–11. PubMed PMID: 26504127. Epub 2015/10/28. engCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Assitant Professor, Pediatric Endocrinology and Metabolism, Department of Pediatrics and Child HealthMax Rady College of Medicine, University of ManitobaWinnipegCanada

Personalised recommendations